Form 8-K - Current report:
SEC Accession No. 0001437749-21-017299
Filing Date
2021-07-21
Accepted
2021-07-21 16:30:43
Documents
2
Period of Report
2021-07-15
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20210721_8k.htm 8-K 23369
2 EXHIBIT 16.1 ex_265781.htm EX-16.1 2664
  Complete submission text file 0001437749-21-017299.txt   27156
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 211104807
SIC: 2834 Pharmaceutical Preparations